Adamas Pharmaceuticals
13F holders, Q4 2024 (December 31)1holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Adamas Pharmaceuticals in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 1 sold out. The largest holder was Public Employees Retirement System of Ohio ($12).
- Company
- Adamas Pharmaceuticals
- CUSIP
- 005CVR014
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $12 |
| Exits | 1 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 117,000 shares bought and 549,557 shares sold, net −432,557 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Public Employees Retirement System of Ohio | 0.00% | New | 117,000 | $12 |
"% of holder's portfolio" is Adamas Pharmaceuticals's weight in each manager's 13F, not the share of Adamas Pharmaceuticals the manager owns.